Pyrosequencing AB.
Pyrosequencing AB develops, manufactures and sells research products that enable life sciences researchers to add utility to the massive amount of genomic information available, with the goal of improving human health. As more genomic information becomes available, research efforts are shifting toward implementing practical applications of this genetic information. Pyrosequencing has developed comprehensive genotyping solutions that provide researchers with rapid and accurate technology for assessing individual genetic variation. Genotypic information is anticipated to play an important role in the emerging field of applied genomics and as a result, significant opportunities may be derived from analyzing genetic variation in individuals and across populations. These data will be key to understanding how genetic differences may be used to determine an individual's predisposition to disease, detect and monitor disease progression, and select the most appropriate therapy and dose and to avoid adverse events. This is pharmacogenomics, an area in which Pyrosequencing technology is being applied and will no doubt continue to enable researchers to ultimately improve human health.
McNeely
Theresa
T
Theresa.McNeely@pyrosequencing.com
D020811:Biomedical Technology; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics; D004345:Drug Industry; D005838:Genotype; D006801:Humans; D010597:Pharmacogenetics; D017149:Private Sector; D017422:Sequence Analysis, DNA
D019389:Cytochrome P-450 CYP2D6